Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.
暂无分享,去创建一个
Pauline M Rudd | Louise Royle | Raymond A Dwek | David J Harvey | R. Dwek | P. Rudd | D. Harvey | R. Peracaula | R. de Llorens | L. Royle | Rosa Peracaula | Glòria Tabarés | Rafael de Llorens | G. Tabarés
[1] T. Stamey,et al. Molecular mass and carbohydrate structure of prostate specific antigen: Studies for establishment of an international PSA standard , 1995, The Prostate.
[2] T. Hill,et al. Different proportions of various prostate‐specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen‐induced LNCaP cells , 2000, The Prostate.
[3] N. Sharon,et al. Protein glycosylation. Structural and functional aspects. , 1993, European journal of biochemistry.
[4] D. Bonn. Predictive value of PSA in prostate cancer is doubtful , 2002 .
[5] C. Cordon-Cardo,et al. Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group‐related antigens , 1997, International journal of cancer.
[6] P. Marker,et al. fucosyltransferase1 and H-type complex carbohydrates modulate epithelial cell proliferation during prostatic branching morphogenesis. , 2001, Developmental biology.
[7] Ajit Varki,et al. Perspectives on the significance of altered glycosylation of glycoproteins in cancer , 1997, Glycoconjugate Journal.
[8] M. Frazier,et al. Ribonucleases expressed by human pancreatic adenocarcinoma cell lines. , 2000, European journal of biochemistry.
[9] M. Brawer,et al. Prostate‐specific antigen: Current status , 1999, CA: a cancer journal for clinicians.
[10] R. Dwek,et al. Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. , 1997, Analytical biochemistry.
[11] R. Vessella,et al. LNCaP produces both putative zymogen and inactive, free form of prostate‐specific antigen , 1998, The Prostate.
[12] U. Stenman,et al. Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. , 1995, Clinical chemistry.
[13] S. Arya,et al. The LNCaP cell line--a new model for studies on human prostatic carcinoma. , 1980, Progress in clinical and biological research.
[14] B. Lyons,et al. Production of milligram concentrations of free prostate specific antigen (fPSA) from LNCaP cell culture: Difference between fPSA from LNCaP cell and seminal plasma , 1998, Journal of clinical laboratory analysis.
[15] Pauline M Rudd,et al. Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states. , 2003, Glycobiology.
[16] R. Dwek,et al. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. , 1996, Analytical biochemistry.
[17] H. Klocker,et al. Expression of Lewis carbohydrate antigens in metastatic lesions from human prostatic carcinoma , 1998, The Prostate.
[18] H. Gross,et al. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels , 1987 .
[19] H. Lilja,et al. Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells , 1999, Prostate Cancer and Prostatic Diseases.
[20] A. Dell,et al. A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator. , 1991, Glycobiology.
[21] M. Blankenstein,et al. Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP , 1993, The Prostate.
[22] O. Vorm,et al. Identification of precursor forms of free prostate-specific antigen in serum of prostate cancer patients by immunosorption and mass spectrometry. , 2001, Cancer research.
[23] P. Malone,et al. Prostate , 1995 .
[24] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[25] Y. Sato,et al. Structural characteristics of the N-glycans of two isoforms of prostate-specific antigens purified from human seminal fluid. , 2001, Biochimica et biophysica acta.
[26] D. Harvey. Quantitative aspects of the matrix-assisted laser desorption mass spectrometry of complex oligosaccharides. , 1993, Rapid communications in mass spectrometry : RCM.
[27] H. Schmid,et al. Serum free prostate specific antigen: Isoenzymes in benign hyperplasia and cancer of the prostate , 1995, The Prostate.
[28] J. Dennis,et al. Protein glycosylation in development and disease , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.
[29] T. Orntoft,et al. Clinical aspects of altered glycosylation of glycoproteins in cancer , 1999, Electrophoresis.
[30] R. Dwek,et al. Analytical and preparative separation of anionic oligosaccharides by weak anion-exchange high-performance liquid chromatography on an inert polymer column. , 1994, Analytical biochemistry.
[31] T. Wheeler,et al. A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue. , 2000, Cancer research.
[32] P. Lange,et al. Sialyl-Lewis(x) and related carbohydrate antigens in the prostate. , 1995, Human pathology.
[33] A. Lu,et al. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml. , 2002, The Journal of urology.
[34] P. Robbins,et al. Glycotyping of prostate specific antigen. , 2000, Glycobiology.
[35] L. Hooper,et al. Oligosaccharides Containing β1,4-Linked N-Acetylgalactosamine, a Paradigm for Protein-specific Glycosylation (*) , 1996, The Journal of Biological Chemistry.
[36] M. Arenas,et al. A lectin histochemistry comparative study in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma , 1999, Glycoconjugate Journal.
[37] R. Oriol. ABO, Hh, Lewis, and Secretion , 1995 .
[38] R. Dwek,et al. Glycobiology , 2018, Biochimie.
[39] H. Lilja,et al. Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors. , 1999, European journal of biochemistry.
[40] A M Ward,et al. Prostate specific antigen: biology, biochemistry and available commercial assays , 2001, Annals of clinical biochemistry.
[41] C. Piskorz,et al. Biosynthesis of the carbohydrate antigenic determinants, Globo H, blood group H, and Lewis b: a role for prostate cancer cell alpha1,2-L-fucosyltransferase. , 2002, Glycobiology.
[42] Carolyn R. Bertozzi,et al. Essentials of Glycobiology , 1999 .
[43] R. Dwek,et al. Sialylated N-glycans in adult rat brain tissue--a widespread distribution of disialylated antennae in complex and hybrid structures. , 1998, European journal of biochemistry.
[44] G. Alivizatos,et al. Prostate specific antigen and benign prostatic hyperplasia , 2000, Current opinion in urology.
[45] M. Vihinen,et al. Androgen-sensitive human prostate cancer cells, LNCaP, produce both N-terminally mature and truncated prostate-specific antigen isoforms. , 1998, European journal of biochemistry.
[46] D. Morton,et al. Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[47] S. Loening,et al. Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[48] R. Parekh,et al. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. , 1995, Analytical biochemistry.
[49] K. Watt,et al. Human prostate-specific antigen: structural and functional similarity with serine proteases. , 1986, Proceedings of the National Academy of Sciences of the United States of America.